Targeting CoV-2 Spike RBD: ACE-II complex with phenolic compounds from Cistus (Cistus L.) Bee Pollen for COVID-19 treatment by Molecular Docking Study
Öz
Spike glycoprotein on the surface of the SARS-CoV-2 is a class I fusion protein that plays a role in the initial attachment of the virus to the human ACE-II receptor. ACE-II has been implicated in the regulation of heart function and also as a functional receptor for the coronavirus that causes the severe acute respiratory syndrome (SARS). In the present study, a molecular docking study was performed using eleven flavonoids present in Cistus bee pollen against the CoV-2 Spike RBD/ACE-II complex and compared their affinity with the FDA approved drug hydroxychloroquine (HCQ).
Binding constants of eleven flavonoids, catechin, pinocembrin, chrysin, caffeic acid phenethyl ester, p-OH Benzoic acid, syringic acid, t-cinnamic acid, p-Coumaric acid, rutin, ferulic acid and gallic acid were measured using the AutoDock 4.2 molecular docking software. Also, these binding constants were then compared to the reference molecule of hydroxychloroquine.
According to docking analysis, the results showed us that catechin has the best inhibiton potential among the all analyzed molecules with the high binding energy (-7.77 kcal/mol) and the lowest Ki (2.03 µM) and it is followed by pinocembrin, chrysin, caffeic acid phenethyl ester, respectively. Besides, the reference molecule hydroxychloroquine has binding energy of -7.53 kcal/mol and 3.04 µM. Consequently, high potential of flavonoids in extracts of Cistus bee pollen to interact with CoV-2 Spike RBD/ACE-II complex indicates that this natural product has high potential for Covid-19 treatment, but this needs to be supported by further studies
Anahtar Kelimeler
Covid-19, Cistus (Cistus L.) Bee Pollen, flavonoids, ,CoV-2 Spike RBD/ACE-II, molecular docking
Kaynakça
- Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., Yuen, K. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections, 9(1), 221-236. DOI: 10.1080/22221751.2020.1719902
- Chen, D., Oezguen, N., Urvil, P., Ferguson, C., Dann, S. M., Savidge, T. C. (2016) Regulation of protein-ligand binding affinity by hydrogen bond pairing. Science advances, 2(3), e1501240.
- Chen, H. & Du, Q. (2020). Potential natural compounds for preventing 2019-nCoV infection. Preprints,: 202001.0358.v1.
- Dassault Systèmes BIOVIA, Discovery Studio Modeling Environment, Release 2017, San Diego: Dassault Systèmes, 2016.
- Fehr, A. R., Perlman, S. (2015). Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol., 2015, 1282:1-23.
- Hughes, J. P., Rees, S., Kalindjian, S. B., Philpott, K. L. (2011). Principles of early drug discovery. British journal of pharmacology, 162(6), 1239-1249.
- Human, H., Nicolson, S. W. (2006). Nutritional content of fresh, bee-collected and stored pollen of Aloe greatheadii var. davyana (Asphodelaceae). Phytochemistry, 67, 1486-1492;
- Ikeno K, Kakimoto K, Nakamura T, Ikeno T, Shinohara R. (2004), Antioxidative activity of honeybee pollen: Comparison with other bee products. Honeybee Science-Tamagawa University (Japan);
- Joshipura, K.J, Hu, F.B., Manson, J.E., Stampfer, M.J., Rimm, E., Frank, E., Colditz, G., Ascherio, A., Rosner, B., Spiegelman, D. and Willett, W. (2001) The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med., 134, 1106–1114.
- Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, Corbett KS, Graham BS, McLellan JS, Ward AB: Pre-fusion structure of a human coronavirus spike protein. Nature 2016, 531(7592):118-121.